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Introduction
Resting levels of several metabolic hormones are 
affected by weight status. Cross-sectional studies have
shown that fasting leptin, insulin and cortisol are higher in
overweight compared to normal weight children and 
adolescents (1,2,3,4,5,6), while growth hormone (GH) levels
are lower (2). These differences may help to explain why
overweight and obese children are at increased risk for
future lifestyle diseases. While these studies highlight
cross-sectional differences in the above-mentioned 
hormones, much less is known about the normal 
progression of these hormonal changes over time. Of the
few longitudinal studies conducted on youth pertaining to
these relationships, most have involved interventions aimed
at reducing body weight or improving body composition. For
example, researchers have reported reductions in insulin
resistance (HOMA-IR) and leptin following substantial
weight loss and increases in these hormones without 
substantial weight loss (7). Similar associations were 
noted for cortisol and insulin in another study by the same
investigators, where significant reductions were found only
in participants who lost substantial weight (8). Only one
study of change in weight status and concomitant change in
GH in youth was found, and these authors reported
increased GH in prepubertal children following a weight loss
program  (9). Taken together, these relatively short-term
studies demonstrate trends for decreased insulin, leptin and
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weight status. However, we know little about the changes
in these hormones that accompany alterations in body or fat
mass over time, as the youth age.
In this investigation, which we believe is the first, 
we describe the changes that occur over a two-year study
period in leptin, insulin, cortisol and GH levels in normal 
and overweight youth and in youth who changed 
their weight status by either becoming overweight or 
normalizing their weight.This approach allowed us to 
compare values of several key metabolic hormones in 
youth who followed a normal pattern of weight gain to
those who deviated from the normal  pattern by changing
their weight status. Finally, this investigation is highly
unique in that it does not involve any type of intervention
and instead, describes natural changes in weight status 
and leptin, insulin, cortisol and GH levels in children of
pubertal ages.
Methods 
Participants were selected from the Cardiovascular
Health in Children III (CHIC) study (J.S. Harrell, who was the
PI of the CHIC study and credit was due). A total of 120 
children of pubertal ages took part in the current study and
the data were obtained by trained research assistants at the
schools at baseline and two years later (follow-up). The 
youth represent all scenarios of weight status over the two-
year period and were analyzed in four groups: normal
weight group [>5th and <85th body mass index (BMI)
percentile for age and sex] at both time points (NN); 
overweight group (≥85th BMI percentile for age and sex) 
at both time points (OO);  the group with normal weight at
baseline and overweight at follow-up (NO); and the group
overweight at baseline  and normal weight at follow-up
(ON). Complete details of participant selection, matching
and weight status scenarios can be found in Ondrak et al (5)
(Table 1). This study did not involve any weight change 
intervention, so changes in weight status were assumed 
to occur as a result of natural processes or changes in
behavior. Participants in the NN and OO groups represent
what we would expect for a  normal growth pattern in
youth who were of normal weight or overweight at both
time points, respectively. Youth in the NO group provide
valuable information about what happens when youth veer
away from a normal growth pattern and become 
overweight, while the reverse is true for the ON group. The
participants signed assent forms and their parent(s) signed
informed consent forms prior to data  collection. All 
procedures were approved by the Institutional Review
Board at the University of North Carolina at Chapel Hill.
Body weight and height were measured using an 
electronic scale (Model 2101KL, Healthometer Medical,
Bridgewater, IL) and a stadiometer (Perspective
Enterprises, Portage, MI). These measurements were
taken with the participant barefoot and excess clothing
removed (and pockets emptied) and were recorded to 
the nearest 0.1 kg and 0.1 cm The measurements were
repeated a second time and the two measurements were
averaged and used to calculate BMI. Research assistants
measured skinfold thickness at the triceps and subscapular
sites, using procedures set forth by the National Health and
Nutrition Examination Survey (1974) (10). Measurements
were taken in triplicate using Lange calipers (Cambridge
Scientific Instruments, Cambridge, MD) and means 
calculated for each site. Percent body fat was calculated
using equations specific to each sex, pubertal stage and
race (11) and these values were used to estimate fat mass
and fat-free mass (ffm).
In addition, pubertal development and aerobic power
were assessed since they have been shown to influence
insulin levels (12,13). Pubertal development was 
self-assessed via a questionnaire (14), while aerobic power
was predicted using a submaximal test performed on the
cycle ergometer, the PWC195 (15). We chose to express
aerobic power in mL/kgffm/min units in order to remove the
influence of fat mass, and focus on the oxygen uptake of
ffm since it is most related to glucose uptake. The 
following equation was used to calculate aerobic power in
mL/kgffm/min.
A blood sample was obtained by standard venipuncture
between 7 and 9 am, following a verified 12 hour fast. The
blood was centrifuged at 4
0C, the plasma separated and
stored at -80
0C until analysis. Insulin, leptin, cortisol and GH
levels were measured in duplicate from the stored plasma
using radioimmunoassay (RIA) procedures (insulin and 
leptin: LINCO Research, St. Charles, MO; GH: MP
Biomedicals, Costa Mesa, CA). The lowest detectable 
limits of these assays were 2 μU/mL, 0.5 ng/mL, and 0.31
ng/mL, respectively. Cortisol was measured using 
solid-phase, single-antibody RIA kits, with a lowest
detectable limit of 0.2 μg/dL (Diagnostic Products
Corporation, Los Angeles, CA). The mean coefficients of
variation for the leptin, insulin, GH, and cortisol assays were
8.1%, 8.0%, 7.2%, and 6.4%, respectively.
Statistical Analysis
In order to identify group differences among participants
at baseline, a one-way ANOVA was completed, comparing
age, pubertal stage, height, weight, BMI, BMI percentile,
percent fat,VO2/kgffm, insulin, leptin, cortisol, and GH.
Likewise, a Mantel-Haenszel chi-square was computed to
reveal group differences at baseline for race and sex. To
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GH over the two-year study period, change scores 
(follow-up - baseline) were calculated for each participant.
Changes in pubertal status were quantified as a 
dichotomous variable in subsequent analyses (no change or
change). In females, change in pubertal stage was defined
as moving from a pubertal stage of 1, 2 or 3 at baseline  to
4 or 5 at follow-up; for males change was defined  as moving
from stages 1 or 2 at baseline to 3, 4 or 5 at follow-up.
Analyses of covariance (ANCOVA) were conducted for
each hormone to determine weight group differences in the
amount of change after controlling for race, sex, and the
hormone values at baseline. Separate ANCOVAs  were
computed for each of the following weight group comparisons:
NO vs. ON, NN vs. NO and OO vs. ON. We included race
as a covariate in the group comparisons, because there was
an unequal distribution of races in each group. Sex was also
a covariate as it is known to influence resting levels of leptin in
youth (16,17). Additionally, initial examination of the data
revealed that the majority of participants with elevated GH
levels were African American females, further supporting
the need for race and sex as covariates in our analyses.
Multiple regression analyses using the stepwise 
selection were performed to determine the association
among changes in each of the hormones for participants in
the NO and ON groups with changes in BMI percentile,
controlling for race, sex and changes in pubertal status and
VO2/kgffm. We controlled for these variables since they are
known to influence insulin in youth (18,19). Collinearity diag-
nostics were calculated to check for collinearity among the
independent variables in the regression models. According
to the recommendations of Belsley et al (20), 
variables would be considered collinear if they had a high
condition index (>30) and at least two variance proportions
that are >0.5. Using these criteria, no variables were
collinear. While the inclusion of only the NO and ON groups
reduced our statistical power for the regression models, we
chose to focus our analyses solely on the participants who
changed their weight status. All statistical analyses were
completed with SAS Statistical Software, Version 9.1
(Cary, NC) and the α level was equal to 0.05.
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Table 1. Participant characteristics (mean ± standard deviation), presented by weight status group at baseline and follow-up
NN NO ON OO
Baseline Follow-up Baseline Follow-up Baseline Follow-up Baseline Follow-up
N3 5 3 5 3 5 3 5 2 5 2 5 2 5 2 5
Age (years)* 9.8±0.9 11.7±0.9 9.2±1.0 11.1±1.0 10.2±1.0 12.0±1.0 10.1±1.1 12.0±1.1
Sex (females, males) 17,18 17,18 14,11 14,11
Race (black, white, other) 21, 13,1 21, 13,1 8, 15, 2 8, 15, 2
Median pubertal  2 (1-4) 3 (1-5) 2 (1-4) 3 (1-4) 2 (1-4) 4 (2-4) 2 (1-4) 3 (1-5)
stage (range)
Body weight (kg)† 34.2±5.3 42.8±6.5 34.9±5.6 49.8±7.6 45.9±8.8 51.6±6.3 53.6±16.1 65.2±18.9
Height (cm)* 141.0±7.3 152.4±8.1 137.0±8.2 148.4±8.9 145.8±8.7 158.5±9.6 143.4±9.1 153.9±9.2
BMI (kg/m2)† 17.1±1.6 18.4±1.7 18.5±1.1 22.5±1.8 21.4±2.3 20.5±0.9 25.7±5.3 27.2±6.0
BMI percentile** 50.8±24.4 51.8±23.1 76.0±8.0 90.2±3.1 89.2±2.9 75.3±9.3 95.3±3.9 94.4±4.2
Fat (%)‡ 16.0±5.3 17.6±7.0 21.6±5.9 26.9±6.0 25.1±5.5 21.2±7.8 31.2±8.2 31.4±9.8
VO2/kgffm^ 51.5±10.9 53.8±9.7 47.9±10.4 47.9±10.0 45.9±12.0 47.2±9.4 42.2±11.9 43.4±10.1
* p<0.05, NO < NN, ON and OO at baseline
† p<0.05, NN and NO < ON < OO at baseline
** p<0.05, NN < NO < ON and OO at baseline
‡ p<0.05, NN < NO < ON < OO at baseline
^ p<0.05, NN < OO at baseline
NN: normal weight group (>5th and <85th BMI percentile for age and sex at both time points) 
NO: group with normal weight at baseline and overweight at follow-up 
ON: group overweight at baseline and normal weight at follow-up 
OO: group overweight at both time points 
BMI: body mass index
ffm: fat-free massResults
The participant characteristics at baseline and follow-up
are shown in Table 1. In general, height, body mass and
pubertal development increased over the two-year period,
as expected. At baseline, participants in the OO and ON
groups had a larger mean BMI percentile than those in the
NN and NO groups. There were group differences in race,
as the NN and NO groups had more black participants than
the ON and OO groups. Participants in the NO group 
were younger than participants in all other groups by
approximately one year (p<0.05). Finally, the OO group had
higher mean insulin and leptin values at baseline, compared
to all other groups.
Weight Groups Comparisons
Both the NO and ON groups underwent a 14-unit
change in BMI percentile, albeit in opposite directions
(Table 1). The NN and OO groups both stayed extremely
stable, with BMI percentile changes of one point or less
over the two years. There were significant differences
between the NO and ON groups for changes in leptin and
cortisol (p<0.001). As shown in Table 2, there was a large
increase in mean leptin levels in the NO group (+205%),
and a slight decrease for the ON group (-21%). For cortisol,
the ON group increased slightly (+13%), while the NO
group decreased by a larger magnitude (-33%). Although
not statistically significant, insulin and GH levels increased
for the NO group (+26% and 53%, respectively) and
decreased in the ON group (-6% and -21%, respectively). 
To describe the changes associated with becoming
overweight, we compared participants in the NO group to
those in the NN group. There were significant differences
for insulin and leptin, as the NO groups had a greater
increase compared to changes in the NN groups (Table 2).
Similarly, the NO group had a larger decline in cortisol, 
compared to the NN group. Finally, when comparing 
participants who normalized their weight (ON) to those who
remained overweight (OO), significant group differences
were found for leptin as the OO group increased markedly,
while the ON group declined. Finally, the OO group had
greater reductions in insulin compared to the ON group,
p<0.05.
Multiple Regression Models
The results of the multiple regression analyses for the
youth who underwent weight status change (NO and ON
groups) showed significant partial correlations between
changes in BMI percentile and changes in insulin 
(R2=0.13), leptin (R2=0.35) and cortisol (R2=0.11) levels,
after adjusting for changes in pubertal status, VO2/kgffm and
race and sex (Table 3 and Figure 1). Despite the small total
R2, change in BMI percentile accounted for the 
greatest amount of variance in changes in leptin, insulin and
cortisol. A graphical representation of the relationship
25
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Table 2.Insulin, leptin, cortisol and GH at baseline and follow-up, and changes in these hormones (mean ± standard deviation), presented by weight status group
NN NO ON OO
Baseline Follow-up Baseline Follow-up Baseline Follow-up Baseline Follow-up
Insulin (μU/mL)* 12.1±10.3 10.8±8.2 13.3±7.1 16.7±11.3 14.4±4.6 13.5±7.7 20.8±9.7 18.4±8.0
Δ Insulin# -1.31±9.16 3.49±11.73 -0.96±6.18 -2.44±11.79
Leptin (ng/mL)^ 1.7±1.1 3.1±2.0 4.0±2.7 12.2±7.6 6.8±5.4 5.4±3.7 15.8±11.7 21.7±15.7
Δ Leptin† 1.43±1.62 8.19±6.83 -1.35±4.88 6.68±11.87
Cortisol (μg/dL) 14.1±5.6 12.0±4.5 14.8±5.5 9.9±4.4 13.5±5.2 15.2±4.9 12.2±6.2 11.4±5.1
Δ Cortisol‡ -2.07±6.18 -4.91±7.18 1.63±5.23 -0.89±7.22
GH (ng/mL) 2.1±3.7 4.0±4.6 1.9±2.4 2.9±3.4 3.9±4.8 3.1±4.2 1.9±2.6 3.3±4.1
Δ GH 1.88±6.34 0.98±3.90 -0.79±6.03 1.35±3.64
* p<0.05, OO > ON, NO and NN at baseline
# p<0.05, NO > NN and OO > ON
^ p<0.05, OO > ON, NO and NN at baseline; ON > NN at baseline
† p<0.05, NO > ON and NN, ON > OO
‡ p<0.05, NO > ON and ON > OO
NN: normal weight group (>5th and <85th BMI percentile for age and sex at both time points) 
NO: group with normal weight at baseline and overweight at follow-up 
ON: group overweight at baseline and normal weight at follow-up 
OO: group overweight at both time points 
GH: growth hormonebetween changes in BMI percentile and changes leptin,
insulin, cortisol and growth hormone can be found in Figure 1.
This figure shows that the strongest relationships are
between changes in BMI percentile and leptin, followed by
changes in insulin and lastly, an inverse relationship with
changes in cortisol.
Discussion 
To our knowledge, this investigation is the first to
describe the longitudinal relationships among natural
changes occurring over time in weight status and changes
in leptin, insulin, cortisol, and GH. A major finding is that
changes in BMI percentile were related to changes in 
leptin, insulin and cortisol, even after controlling for factors
known to influence these variables. Furthermore, our data
suggested youth who became overweight over the study
period had larger changes in these hormones than 
overweight youth who reverted to normal weight. When all
hormonal relationships were considered, the strongest
association was between change in BMI percentile and
change in leptin (Table 3). Likewise, the largest differences
were found for leptin (NO=205% increase vs. ON=21%
decrease). Taken together, these findings suggest that of
the four hormones analyzed, changes in leptin are the most
sensitive to changes in weight status (21,22). The trends in
leptin change of the ON and OO groups are similar to 
findings reported by Reinehr et al (7). Other studies have
reported larger reductions in leptin in response to weight
loss programs, which may be attributable to the greater
starting values for leptin and percent body fat or BMI in
their participants (23,24,25). Additionally, the relatively
small change in leptin in the ON group in our study 
may be due to our classification of weight status. Our ON
participants were only moderately overweight at baseline
(mean of 89th BMI percentile) and they were at the very
high end of the normal weight range (~75th BMI percentile)
at follow-up. If these participants had started or ended with
a higher or lower BMI percentile, respectively, greater
changes in leptin, and all other hormones, may have been
observed. Finally, it is important to point out that changes in
weight status in our investigation were not invoked by an
intervention per se, and they occurred as a result of natural
processes over a two-year period. Thus, the related
changes in hormones may differ markedly from studies that
used a weight change intervention approach.
The large increase in leptin in the NO groups may be
explained by the 79% increase in fat mass from baseline to
follow-up, since leptin is released from adipocytes (21).
Researchers have proposed a theoretical model of the 
relationship between insulin, leptin and adipose tissue,
termed the “adipo-insular” axis, which may help to explain
our findings (26). In this axis, insulin is thought to 
increase the release of leptin from adipose tissue, while
leptin decreases the release of insulin. The smaller 
relative change in insulin in the current investigation may be
partially explained by an inhibition of its release by
increased leptin. Viewed collectively, our findings support
the concept of an “adipo-insular” axis and an association
between changes in leptin and insulin in children of 
pubertal ages.
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Table 3. Multiple regression models of changes in insulin, leptin, 
cortisol and GH with respect to changes in BMI percentile, pubertal
status, VO2/kgffm, as well as sex and race for participants who 
underwent change in weight status
Dependent Independent  Partial  and 
Variable Variables Total R2
Δ Insulin Δ BMI %tile 0.13*
Δ pstat 0.06*
Sex 0.05
Total R2 0.24*
Δ Leptin Δ BMI %tile 0.35*
Δ pstat 0.03
race 0.03
Sex 0.03
Total R2 0.43*
Δ Cortisol Δ BMI %tile 0.12*
Δ VO2/kgffm 0.11*
Total R2 0.23*
Δ GH Δ pstat 0.07*
Total  R2 0.07*
* p<0.05
GH: growth hormone, BMI: body mass index
Figure 1. Scatterplots of changes in insulin, leptin, cortisol and GH
and change in BMI percentile over two years for youth who increased
(NO) or decreased (ON) their weight status
NO: normal to overweight 
ON: overweight to normal weight
Change in BMI percentile Change in BMI percentile
Change in BMI percentile Change in BMI percentile
C
h
a
n
g
e
 
i
n
 
C
o
r
t
i
s
o
l
C
h
a
n
g
e
 
i
n
 
I
n
s
u
l
i
n
C
h
a
n
g
e
 
i
n
 
L
e
p
t
i
n
C
h
a
n
g
e
 
i
n
 
G
HThe inverse association between changes in BMI 
percentile and cortisol was significant, but in the opposite
direction of what we expected from previous research.
These findings are somewhat puzzling, considering that the
group means for cortisol were similar to previous reports
for both normal (2,8) and overweight youth (2,8,27). In 
contrast to our findings, Reinher and Andler (8), 
using obese, insulin resistant subjects, reported reductions
in cortisol after a one-year weight reduction program. Their
results may have differed from our investigation due to the
weight reduction intervention conducted in their study,
leading to alterations in diet and exercise, or to the greater
magnitude of weight change noted in the subjects.
Regrettably, while the actual change in weight or fat mass
was not reported in their investigation, the mean weight
change was a reduction of approximately 3.3 BMI units,
whereas the youth in our ON group experienced a BMI
reduction of only 0.9 kg/m2. Other factors that may explain
why our groups did not follow expected trends include 
the small absolute changes in cortisol with large standard
deviations, and the within day variation in cortisol due to its
circadian pattern of release (28). However, we obtained our
samples between 7-9 am in a standardized fashion in an
attempt to minimize this influence.
The change in GH did not differ among any of the
weight status groups (p>0.05), and the magnitude of
change was quite small. Notably, the NO group increased
slightly, while the ON group decreased by a similar amount
over the two-year study period. These results have not
been reported previously and may be attributable to the 
low mean GH values and the large standard deviations in
youth in this age group. These factors make it difficult to
detect changes, which may have occurred specifically in
response to weight status change. Also, our GH values
were slightly lower than those previously reported for 
children of normal weight (29,30) and slightly higher than
reported values for obese youth (9,29). Perhaps, if we had
been able to take serial samples we may have been able to
take into consideration the pulsatile nature of GH release,
which may have provided more reliable results.
Athough a significant, inverse relationship between 
aerobic power per kilogram lean body mass and insulin was
reported in a previous study (18), we failed to detect an
association among changes in VO2/kgffm and changes in
insulin, leptin or GH. These results suggest that fat mass
may be a more critical component influencing these 
hormonal changes than fat-free mass. Additionally, our
results may have differed from the investigation reported
by Allen et al (18), as their participants were obese (BMI
>95th percentile) and the study was assessing cross-
sectional relationships. Finally, the two-year changes in
VO2/kgffm in our study were relatively small (3%), which
may explain why we did not detect associations in their
change scores in relation to the hormonal changes.
There were a number of strengths and weaknesses in
this investigation. Our design was highly unique as it 
examined normal changes in weight status, as opposed to
those caused by an intervention. This design improves the
generalizability of our results, as the vast majority of 
children are not involved in weight change intervention 
programs. By studying those who increased, decreased or
maintained their weight status, we have representation
from all possible scenarios of weight status change in 
youth of this age group. These distinctions are important
when using longitudinal designs in youth, since they are
likely to gain weight as they grow, but their BMI percentile
may actually be decreasing if their height is increasing at a
faster rate than their body weight. Additionally, the 
classification of normal weight and overweight used in this
study is commonly used by practitioners and researchers 
to delineate levels of disease risk and to make health 
recommendations. Examination of the NO and ON groups
in particular allows us to describe what happens when 
youth move from a recommended weight status to one
associated with increased risk, or vice versa and importantly,
fail to track from year to year. 
A limitation associated with this investigation is the 
variability in hormone levels. Leptin (31) and GH (9,32) are
released in a pulsatile fashion and cortisol is also pulsatile
and exhibits a circadian rhythm (33). By only obtaining one
blood sample at each time point, it is difficult to determine
if the hormone levels varied due to the time of day or other
factors such as weight status. In an effort to reduce 
the effect of diurnal variability on hormone levels, we 
standardized the time of day during which blood samples
were taken. However, future investigations in this area may
consider repeated sampling of hormones throughout the
day (34). Another limitation of our study is the variation in
race and pubertal status among participants. We attempted
to account for these differences by matching participants in
the NO and ON groups to those in the NN and OO groups
by their race and pubertal status at baseline; however, race
may still have influenced our hormonal results. It is 
also known that children may progress through puberty at
different rates and this is another potential limitation of this
study. Nevertheless, the influence of pubertal stage change
was likely to be small, as 83% of the participants had either
no change or an advance of only one pubertal stage over
the two-year study period.
In conclusion, in a sample of children of pubertal ages
who increased or decreased their weight status over a 
two-year period, changes in BMI percentile were positively
related to changes in leptin and insulin levels, inversely
related to changes in cortisol and not related to changes in
GH levels. Youth who became overweight showed 
larger changes in leptin and cortisol than overweight 
youth who reverted to normal weight. The results also 
suggest that gain in weight status has more of an impact on
hormonal changes than reduction in weight status. It is 
possible that the favorable changes associated with normal
reductions in weight status take longer to accrue than the
negative effects of increase in weight status.
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